USPTO serial 76269498
T3
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- ORNDORFF, LINDA
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with T3?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert Miklautsch
ROBERT MIKLAUTSCH SOKOLOW, DUNAUD, MERCADIER & CARRERAS770 LEXINGTON AVE FL 6NEW YORK, NY 10021-8165UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting the goods and services of others by offering product samples and promotional material | ACTIVE | Feb 22, 2001 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 26, 2002 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Aug 12, 2002 | PAPER RECEIVED | — | |
| Jan 4, 2002 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 4, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 14, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 10, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 3, 2001 | DOCK | ASSIGNED TO EXAMINER | — |